In:
The Journal of Pediatric Pharmacology and Therapeutics, Pediatric Pharmacy Advocacy Group, Vol. 18, No. 2 ( 2013-01-01), p. 137-141
Abstract:
The drug of choice for treatment of Stenotrophomonas maltophilia is sulfamethoxazole/trimethoprim, and second-line therapy usually consists of a fluoroquinolone. However, in patients with glucose-6-phosphate dehydrogenase deficiency, neither sulfamethoxazole/trimethoprim nor a fluoroquinolone is a preferred option as it may result in hemolysis. Currently, there is a paucity of data regarding treatment of S maltophilia infection in these patients. This case report presents a patient who was successfully treated with doxycycline and inhaled colistimethate.
Type of Medium:
Online Resource
ISSN:
1551-6776
DOI:
10.5863/1551-6776-18.2.137
Language:
English
Publisher:
Pediatric Pharmacy Advocacy Group
Publication Date:
2013
detail.hit.zdb_id:
3028543-4